![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 9, 6803-6808, February 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The amyloid precursor protein is cleaved within
its ectodomain by
The Transmembrane Domain of the Amyloid Precursor Protein in
Microsomal Membranes Is on Both Sides Shorter than Predicted*
§,
,
,
, and

Center for Molecular Biology Heidelberg,
University of Heidelberg, INF 282, D-69120 Heidelberg, Germany, the
¶ Department of Pathology, University of Melbourne, Parkville,
Victoria 3052, Australia, and the ** Massachusetts General
Hospital/Harvard Medical School,
Boston, Massachusetts 02114
-amyloid-converting enzyme (BACE) yielding
C99, which is further cleaved by
-secretase within its putative
transmembrane domain (TMD). Because it is difficult to envisage how a
protease may cleave within the membrane, alternative mechanisms have
been proposed for
-cleavage in which the TMD is shorter than
predicted or positioned such that the
-cleavage site is accessible
to cytosolic proteases. Here, we have biochemically determined
the length of the TMD of C99 in microsomal membranes. Using a single
cysteine mutagenesis scan of C99 combined with cysteine modification
with a membrane-impermeable labeling reagent, we identified which
residues are accessible to modification and thus located outside of the membrane. We find that in endoplasmic reticulum-derived
microsomes the TMD of C99 consists of 12 residues that span from
residues 37 to 48, which is N- and C-terminally shorter than predicted. Thus, the
-cleavage sites are positioned around the middle of the
lipid bilayer and are unlikely to be accessible to cytosolic proteases.
Moreover, the center of the TMD is positioned at the
-cleavage site
at residue 42. Our data are consistent with a model in which
-secretase is a membrane protein that cleaves at the center of the membrane.
*
This work was supported by the Deutsche
Forschungsgemeinschaft (DFG) through the Graduate College for
Biotechnology (to K. B.), by a grant of the Bundesministerium
für Bildung und Forschung and the DFG (to T. H. and
K. B.), and by the European Union (QLRT-2002-172) (to T. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.

Supported by an Emmy Noether Fellowship of the DFG.
This article has been cited by other articles:
![]() |
M. O. W. Grimm, H. S. Grimm, I. Tomic, K. Beyreuther, T. Hartmann, and C. Bergmann Independent Inhibition of Alzheimer Disease {beta}- and {gamma}-Secretase Cleavage by Lowered Cholesterol Levels J. Biol. Chem., April 25, 2008; 283(17): 11302 - 11311. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eggert, K. Paliga, P. Soba, G. Evin, C. L. Masters, A. Weidemann, and K. Beyreuther The Proteolytic Processing of the Amyloid Precursor Protein Gene Family Members APLP-1 and APLP-2 Involves {alpha}-, {beta}-, {gamma}-, and {epsilon}-Like Cleavages: MODULATION OF APLP-1 PROCESSING BY N-GLYCOSYLATION J. Biol. Chem., April 30, 2004; 279(18): 18146 - 18156. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Grimm, D. Beher, S. F. Lichtenthaler, M. S. Shearman, K. Beyreuther, and T. Hartmann gamma -Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid beta J. Biol. Chem., April 4, 2003; 278(15): 13077 - 13085. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |